Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies (Q35892161)

11 August 2017

1 reference

title

Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies (English)

1 reference

11 August 2017

William C Stanley

1

1 reference

11 August 2017

1 September 2004

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

11 August 2017

1 reference

11 August 2017

9 Suppl 1

1 reference

11 August 2017

S31-45

1 reference

Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective

11 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Regulation of oxidative phosphorylation in the mammalian cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Control of mitochondrial respiration in the heart in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

21 January 2018

Ventricular energetics

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Regulation of fatty acid oxidation in the mammalian heart in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Plasma fatty acid levels in infants and adults after myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Effects of acute hyperglycemia on myocardial glycolytic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Fatty acid transport: the roads taken

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Cardiac fatty acid uptake and transport in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Critical steps in cellular fatty acid uptake and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Ranolazine: a novel metabolic modulator for the treatment of angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Fatty acid import into mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Malonyl CoA control of fatty acid oxidation in the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Regulation of myocardial glucose uptake and transport during ischemia and energetic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Increased nonoxidative glycolysis despite continued fatty acid uptake during demand-induced myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Improved energy homeostasis of the heart in the metabolic state of exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Regulation of annexin I in adipogenesis: cAMP-independent action of methylisobutylxanthine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Fuel selection in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: effect of diabetes, fasting, and refeeding on pyruvate dehydrogenase interconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Effects of glycogen stores and non-esterified fatty acid availability on insulin-stimulated glucose metabolism and tissue pyruvate dehydrogenase activity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Partial inhibition of fatty acid oxidation increases regional contractile power and efficiency during demand-induced ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Energy metabolism in the normal and failing heart: potential for therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Effect of Free Fatty Acids on Myocardial Function and Oxygen Consumption in Intact Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Long-chain fatty acids activate calcium channels in ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Amiloride delays the ischemia-induced rise in cytosolic free calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Reflexes mediated by cardiac sympathetic afferents during myocardial ischaemia: role of adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

New look to an old symptom: angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

ST-segment elevation in the electrocardiogram: a sign of myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Molecular basis of electrocardiographic ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Acute hibernation decreases myocardial pyruvate carboxylation and citrate release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Partial fatty acid oxidation inhibitors for stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Comparative trial of perhexiline maleate and oxprenolol in patients with angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900104

10.1177/107424840400900104

21 January 2018

Identifiers

DOI

0 references

PubMed ID

15378130

1 reference

PubMed ID

15378130